COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT - Patent 3362094

(19)

(11)

EP 3 362 094 A1

(12)

(43)	Date of publication:
	22.08.2018 Bulletin 2018/34

(21)	Application number: 16784442.2

(22)	Date of filing: 14.10.2016

(51)

International Patent Classification (IPC):

A61K 45/06^(2006.01)
A61K 31/136^(2006.01)
A61K 31/4453^(2006.01)
A61K 31/5375^(2006.01)
A61K 33/24^(2006.01)
A61P 35/00^(2006.01)

A61K 31/131^(2006.01)
A61K 31/137^(2006.01)
A61K 31/498^(2006.01)
A61K 31/704^(2006.01)
A61K 33/36^(2006.01)
G01N 33/50^(2006.01)

(86)	International application number:
	PCT/EP2016/074682

(87)	International publication number:
	WO 2017/064241 (20.04.2017 Gazette 2017/16)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

15.10.2015 EP 15306650

(71)	Applicant: Advanced Biodesign
	69800 Saint Priest (FR)

(72)	Inventors:
	CEYLAN, Ismail 69800 Saint-priest (FR) QUASH, Gerry 69800 Saint-priest (FR) PEREZ-ALEA, Mileidys 69800 Saint-priest (FR) MARTIN, Guillaume 69800 Saint-priest (FR)

(74)	Representative: Lavoix
	62, rue de Bonnel 69448 Lyon Cedex 03 69448 Lyon Cedex 03 (FR)

(54)	COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT